PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Dec-2023 Biosynth to Offer Complex Chemistry Solutions at Greater Scales Following Acquisition of VIO Chemicals Biosynth
19-Dec-2023 New hot-flush treatment VEOZA▼™ (fezolinetant): first-in-class non-hormonal medicine for moderate to severe vasomotor symptoms associated with menopause licensed in Great Britain Astellas Pharma Inc
19-Dec-2023 Shionogi announces agreement with SOBI on Fetcroja®▼ (cefiderocol) to expand access for patients with infections due to aerobic Gram-negative organisms in adults with limited treatment options. Shionogi B.V.
19-Dec-2023 Santhera’s AGAMREE (Vamorolone) Approved in the European Union for the Treatment of Duchenne Muscular Dystrophy Santhera Pharmaceuticals
19-Dec-2023 Recipharm Harmonises its Global Quality Operations with Veeva Vault Quality Veeva Systems
19-Dec-2023 Shorla Oncology & EVERSANA Announce U.S. Commercial Launch of FDA-Approved JYLAMVO, the First and Only Oral Methotrexate Solution Approved in the U.S. for Adults Shorla Oncology
19-Dec-2023 CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE CureVac
19-Dec-2023 Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees Mainz BioMed N.V.
19-Dec-2023 SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance SCHOTT Pharma AG & Co. KGaA
19-Dec-2023 Evotec receives US$ 2.5 m grant to leverage human iPSC-derived teratogenicity platform for global health programmes Evotec SE
18-Dec-2023 Marinomed Biotech AG evaluates strategic options for Carragelose portfolio Marinomed Biotech AG
18-Dec-2023 Marinomed Biotech AG evaluates strategic options for Carragelose portfolio Marinomed Biotech AG
18-Dec-2023 Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration Xlife Sciences AG
15-Dec-2023 2024 Voluntary Scheme agreement published ABPI
15-Dec-2023 Original-Research: HAEMATO AG (von GBC AG) HAEMATO AG
14-Dec-2023 DOUGLAS: Publication of results for the 4th quarter 2022/23 (ending 30 September 2023) on 20 December 2023 Douglas GmbH
14-Dec-2023 A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application Medacta Group SA
14-Dec-2023 A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application Medacta Group SA
14-Dec-2023 ProBioGen Was Granted a New Patent for DirectedLuck® Transposase Technology B3C newswire
14-Dec-2023 1ST Biotherapeutics, Inc. Announces First Patient Dosed in Phase I/II Study of HPK1 Inhibitor FB849 in Patients with Advanced Solid Tumors 1ST Biotherapeutics